— Know what they know.
Not Investment Advice

NGMDF OTC

NuGen Medical Devices Inc.
1W: +0.0% 1M: +0.0% 3M: -39.3% YTD: -62.0% 1Y: -76.2% 3Y: -93.3%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 39 · $2.2M mcap · 222M float · 0.0007% daily turnover · Short 64% of daily vol

Balance Sheet Trends

Total Assets
$13M +85.6% ▲
5Y CAGR: +93.7%
Total Liabilities
$19M +106.2% ▲
5Y CAGR: +242.7%
Shareholders Equity
-$6M -175.3% ▼
Cash & Investments
$7M +1395.5% ▲
5Y CAGR: +71.2%
Total Debt
$18M +125.8% ▲
5Y CAGR: +123.5%
Net Debt
$11M +46.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$266K$2M$131K$464K$7M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$266K$2M$131K$464K$7M
Net Receivables$145K$311K$243K$355K$330K
Inventory$10K$13K$77K$209K$321K
Other Current Assets$6M$0$0$50K$52K
Total Current Assets$6M$2M$567K$1M$8M
Property, Plant & Equip.$27K$18K$163K$31K$9K
Goodwill & Intangibles$8M$7M$6M$6M$5M
Long-Term Investments$26K$0$0$0$0
Other Non-Current Assets$269K$0$0$0$0
Total Non-Current Assets$8M$7M$6M$6M$5M
Total Assets$15M$9M$7M$7M$13M
— Liabilities —
Accounts Payable$820K$878K$1M$971K$666K
Short-Term Debt$3M$325K$83K$2M$575K
Deferred Revenue$21K$0$37K$52K$82K
Other Current Liabilities$6M$0$0$0$0
Total Current Liabilities$10M$1M$2M$3M$1M
Long-Term Debt$5M$6M$7M$6M$17M
Other Non-Current Liab.$923K$346K$175K$0$0
Total Non-Current Liabilities$6M$6M$7M$6M$17M
Total Liabilities$15M$7M$9M$9M$19M
— Equity —
Common Stock$7M$14M$15M$21M$23M
Retained Earnings-$9M-$16M-$21M-$29M-$34M
Accumulated OCI$1M$3M$3M$6M$5M
Total Stockholders Equity-$692K$2M-$2M-$2M-$6M
Total Liabilities & Equity$15M$9M$7M$7M$13M
— Key Metrics —
Total Debt$7M$6M$7M$8M$18M
Net Debt$7M$4M$7M$7M$11M
Total Investments$26K$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms